편집
13,656
번
새 문서: Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration (EXCITE) == 연구의 목적 == ranibizumab...
(새 문서: Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration (EXCITE) == 연구의 목적 == ranibizumab...) |
(차이 없음)
|